| 林春龙,张珍祥,徐永健.川芎嗪和尼群地平配伍治疗慢性阻塞性肺病的机制探讨[J].,2001,(1):28-30 |
| 川芎嗪和尼群地平配伍治疗慢性阻塞性肺病的机制探讨 |
| Therapeutic Mechanism of Combination Therapy of Ligustrazine and Nitrendipine in Treating Patients with Chronic Obstructive Pulmonary Disease |
| |
| DOI： |
| 中文关键词: 川芎嗪 尼群地平 配伍 慢性阻塞性肺病 血液流变学 内皮素1 血栓素A2 血小板P选择素 |
| 英文关键词:ligustrazine nitrendipine combination chronic obstructive pulmonary disease hemorrheology endothelin-1 thromboxane A 2 platelet-P-selectin |
| 基金项目:国家“八五”资助课题部分内容! (No .8591 50 2 1 3) |
|
| Hits: 1447 |
| Download times: 1155 |
| 中文摘要: |
| 目的 :探讨川芎嗪与尼群地平降低慢性阻塞性肺病 (慢阻肺 )患者肺循环阻力的治疗机制。方法 :分别应用川芎嗪、尼群地平及川芎嗪与尼群地平配伍 3种方法治疗慢阻肺患者各 10例 ,测定用药前后血液流变学参数及血浆内皮素 1(ET1)、血栓素A2 (TXA2 )、血小板 -P -选择素 (CD62P)等水平。结果 :川芎嗪与尼群地平配伍能降低血浆ET1、TXA2 、CD62P水平 ,同时下调血液流变学各指标。结论 :川芎嗪与尼群地平配伍能增强各自单独用药的效果 ,其降低肺循环阻力的作用与降低血浆中缩血管因子及改变血液流变学有关。 |
| 英文摘要: |
| To study the therapeutic mechanism of combination therapy of ligustrazine and nitrendipine in treating patients with chronic obstructive pulmonary disease (COPD). Methods: Thirty COPD patients divided in to 3 groups (10 in each) were treated with ligustrazine, nitrendipine and ligustrazine plus nitrendipine respectively, and the changes of hemorrheologic parameters, plasma endothelin (ET-1), thromboxane A 2 (TXA 2) and platelet-P-selectin (CD62P) before and after treatment were observed. Results: The combination therapy of ligustrazine and nitrendipine could lower the levels of plasma ET-1, TXA 2, CD62P and the hemorrheologic parameters. Conclusion: Combination of ligustrazine and nitrendipine showed a therapeutic effect better than that of the two drugs used separately. Its effect in lowering pulmonary circulation resistance is related with the lowering of plasma vaso-contrictive factor and the changing of hemorrheologic properties. The integrated traditional Chinese and western medical therapy is valuable in treating COPD. |
| View Full Text View/Add Comment Download reader |
